Volume 23, Number 8—August 2017
CME ACTIVITY - Research
Human Metapneumovirus and Other Respiratory Viral Infections during Pregnancy and Birth, Nepal
Table 3
Measure | Total, n = 55 | Pregnant, n = 25 | Postpartum, n = 30 | p value |
---|---|---|---|---|
Symptom, no. (%) | ||||
Fever† | 55 (100) | 25 (100) | 30 (100) | NA |
Cough | 37 (67) | 17 (68) | 20 (67) | 0.92 |
Sore throat | 23 (42) | 11 (44) | 12 (40) | 0.76 |
Rhinorrhea/nasal congestion | 32 (58) | 15 (60) | 17 (57) | 0.80 |
Myalgia | 31 (56) | 12 (48) | 19 (63) | 0.25 |
Visit for care |
27 (49) |
12 (48) |
18 (60) |
0.49 |
Severity measure, median (range) | ||||
Severity score | 10 (1–61) | 13 (3–61) | 9 (1–38) | 0.70 |
Fever duration, d | 3 (1–8) | 3 (1–8) | 2 (1–8) | 0.15 |
Cough duration, d | 2 (0–27) | 3 (0–27) | 2 (0–10) | 0.78 |
Symptom duration, d | 5 (1–31) | 5 (2–31) | 5 (1–28) | 0.36 |
*NA, not applicable.
†Subjective fever required for nasal swab specimen collection.
Page created: July 11, 2017
Page updated: July 13, 2017
Page reviewed: July 13, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.